Relationship of serum Fetuin-A with metabolic and vascular parameters in patients with prediabetes and type 2 diabetes mellitus

被引:0
|
作者
Karamfilova, Vera [1 ]
Nedeva, Iveta [2 ]
Gatev, Tsvetan [1 ]
Gateva, Antoaneta [1 ]
Assyov, Yavor [1 ]
Gerganova, Antonina [1 ]
Popov, Dobrin [1 ]
Velikova, Tsvetelina [3 ]
Kamenov, Zdravko [1 ]
机构
[1] Med Univ Sofia, Univ Hosp Alexandrovska, Dept Internal Med, Clin Endocrinol & Metab Dis, Sofia, Bulgaria
[2] Med Univ Sofia, Dept Hyg & Epidemiol, Sofia, Bulgaria
[3] Univ Hosp Lozenetz, Dept Clin Immunol, Sofia, Bulgaria
关键词
Fetuin-A; prediabetes; type 2 diabetes mellitus; vascular parameters; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; RISK; ASSOCIATION; ATHEROSCLEROSIS; EXPRESSION; MORTALITY; INDEX;
D O I
10.3897/pharmacia.70.e115795
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Fetuin-A is a multifunctional liver-derived glycoprotein that is associated with insulin resistance and might play a role in the pathogenesis of prediabetes and type 2 diabetes (T2DM). Objective: This study evaluated the relationship of Fetuin-A with metabolic and vascular parameters in patients with prediabetes and T2DM. Materials and methods: total 120 obese patients were included. They were divided into three groups: group 1 - without carbohydrate disturbances, group 2 - with prediabetes and group 3 - with type 2 diabetes mellitus. Results: Higher Fetuin-A serum levels were observed in patients with prediabetes and T2DM compared to those with normoglycemia. Fetuin-A >= 821 mcg/ml increased the risk for T2DM 32-fold. Additionally, we found positive correlations between Fetuin-A, vibration perception threshold and toe-brachial index and a negative correlation with neuropathy disability score. Conclusion: Fetuin-A could be predictive for incidents of prediabetes and T2DM.
引用
收藏
页码:1455 / 1461
页数:7
相关论文
共 50 条
  • [1] Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus
    Mori, Katsuhito
    Emoto, Masanori
    Araki, Takahiro
    Yokoyama, Hisayo
    Lee, Eiko
    Teramura, Megumi
    Koyama, Hidenori
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (09): : 1248 - 1252
  • [2] Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients?
    Berezin, Alexander
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (03) : 169 - +
  • [3] Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus
    Gunduz, Fethiye Oztop
    Yildirmak, Sembol Turkmen
    Temizel, Mustafa
    Faki, Yilmaz
    Cakmak, Mustafa
    Durmuscan, Mustafa
    Sezgin, Funda
    [J]. DIABETES & METABOLISM JOURNAL, 2011, 35 (05) : 523 - 528
  • [4] Fetuin-A and type II diabetes mellitus
    Lamyaa Ismail Ahmed
    Sabila Gomaa Mousa
    Nagwa Abd El-Ghaffar Mohamed
    Zeinab Ahmed Yousry
    Mayada Rabea Abd-El Khalaa
    [J]. The Egyptian Journal of Internal Medicine, 2014, 26 (4) : 157 - 161
  • [5] Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus
    Emoto, Masanori
    Mori, Katsuhito
    Lee, Eiko
    Kawano, Naoya
    Yamazaki, Yuko
    Tsuchikura, Shoko
    Morioka, Tomoaki
    Koyama, Hidenori
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (06): : 873 - 878
  • [6] Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
    Sazan Rasul
    Ludwig Wagner
    Alexandra Kautzky-Willer
    [J]. Endocrine, 2012, 42 : 496 - 505
  • [7] Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
    Rasul, Sazan
    Wagner, Ludwig
    Kautzky-Willer, Alexandra
    [J]. ENDOCRINE, 2012, 42 (03) : 496 - 505
  • [8] Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes
    Jung, Chan-Hee
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Jung, Sang-Hee
    Mok, Ji-Oh
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (05): : 459 - 467
  • [9] Role of Fetuin-A and vascular endothelial growth factor In type 2 diabetes mellitus patients without and with retinopathy
    Priya, Ezhumalai
    Jayashree, Kuppuswami
    Senthilkumar, Gandhipuram Periyasamy
    Yasir, Md
    Babu, Ramesh K.
    Devi, Thiyagarajan Durga
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2699 - 2703
  • [10] RELATIONSHIP OF FETUIN-A TO LIPID ABNORMALITIES ASSOCIATED WITH METABOLIC SYNDROME IN TYPE 2 DIABETES MELLITUS (T2DM)
    Eraso, Luis H.
    Ginwala, Naeema
    Qasim, Atif N.
    Mehta, Nehal N.
    Reilly, Muredach P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)